These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 23063971)
1. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis. Singh S; Singh PP; Singh AG; Murad MH; Sanchez W Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971 [TBL] [Abstract][Full Text] [Related]
2. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis. Chang Y; Liu Q; Zhou Z; Ding Y; Yang M; Xu W; Chen K; Zhang Q; Wang Z; Li H Technol Cancer Res Treat; 2020; 19():1533033820934881. PubMed ID: 32552476 [TBL] [Abstract][Full Text] [Related]
3. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population. Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090 [TBL] [Abstract][Full Text] [Related]
4. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma. Wang Y; Wang W; Wang M; Shi J; Jia X; Dang S Can J Gastroenterol Hepatol; 2022; 2022():5389044. PubMed ID: 35356132 [TBL] [Abstract][Full Text] [Related]
5. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study. Kim G; Jang SY; Nam CM; Kang ES J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150 [TBL] [Abstract][Full Text] [Related]
6. Statins use and risk of depression: a systematic review and meta-analysis. Parsaik AK; Singh B; Murad MH; Singh K; Mascarenhas SS; Williams MD; Lapid MI; Richardson JW; West CP; Rummans TA J Affect Disord; 2014 May; 160():62-7. PubMed ID: 24370264 [TBL] [Abstract][Full Text] [Related]
7. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis. Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777 [TBL] [Abstract][Full Text] [Related]
8. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis. Singh S; Singh PP; Singh AG; Murad MH; Sanchez W Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014 [TBL] [Abstract][Full Text] [Related]
9. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis. Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293 [TBL] [Abstract][Full Text] [Related]
10. Statins and primary liver cancer: a meta-analysis of observational studies. Pradelli D; Soranna D; Scotti L; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G Eur J Cancer Prev; 2013 May; 22(3):229-34. PubMed ID: 23010949 [TBL] [Abstract][Full Text] [Related]
11. Statins on hepatocellular carcinoma risk in hepatitis B or C patients protocol for a systematic review and meta-analysis. Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y Medicine (Baltimore); 2018 Aug; 97(34):e11950. PubMed ID: 30142817 [TBL] [Abstract][Full Text] [Related]
12. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. Tsan YT; Lee CH; Wang JD; Chen PC J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485 [TBL] [Abstract][Full Text] [Related]
13. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis. Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891 [TBL] [Abstract][Full Text] [Related]
14. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128 [TBL] [Abstract][Full Text] [Related]
15. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma. Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717 [TBL] [Abstract][Full Text] [Related]
16. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. El-Serag HB; Johnson ML; Hachem C; Morgana RO Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359 [TBL] [Abstract][Full Text] [Related]
17. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden. Björkhem-Bergman L; Backheden M; Söderberg Löfdal K Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765 [TBL] [Abstract][Full Text] [Related]
18. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis. Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695 [TBL] [Abstract][Full Text] [Related]
19. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis. Wang J; Li X Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428 [TBL] [Abstract][Full Text] [Related]
20. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study. Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]